Core Viewpoint - Zentek Ltd. has received a favorable judgment from the Ontario Superior Court, dismissing claims originally exceeding $6 million against the company, which marks a significant legal victory for Zentek [1]. Background - The litigation stemmed from the removal of Aubrey Eveleigh, the company's founder and former CEO, by shareholders during a special meeting on May 11, 2018 [1]. - Two companion actions were tried together in court, focusing on claims made by Mr. Eveleigh and his consulting firm [1]. Outcome - The court dismissed nearly all claims made by Mr. Eveleigh, including: - A Success Fee claim of $282,500, denied due to the lack of a pre-feasibility study [1]. - Severance claims totaling $1,350,000, found void and unenforceable due to breaches of fiduciary duty [1]. - Unpaid wages of $51,748.82, denied [1]. - Defamation damages of $75,000, denied as the statements were deemed factually accurate [1]. - Indemnification claims of approximately $194,000, denied [1]. - Zentek's claim for the cancellation of 4.5 million founder shares was upheld, with the court confirming the shares were properly issued [1]. CEO Comment - The CEO of Zentek, Moe Jiwan, stated that the judgment concludes a significant chapter in the company's history and emphasized the importance of focusing on execution in various projects moving forward [1]. Company Overview - Zentek Ltd. is a Canadian intellectual property development and commercialization company that focuses on graphene-enabled and advanced material technologies, particularly in clean air, next-generation materials, and critical minerals [1].

Core Insights - Zentek Ltd. has announced a strategic reset aimed at capital discipline, sharper execution, and focusing on a smaller number of core platforms with clear paths to value creation [1][4] Strategic Focus - The company will narrow its focus to three core platforms: Albany Graphite, ZenGUARD, and Triera, each with defined milestones and a 24-month roadmap [2] - Non-core initiatives are being paused or wound down to preserve capital and management focus [2] Cost Management - Actions are underway to reduce the company's cost base, including workforce and facility optimization, tighter controls on corporate spending, and a disciplined approach to capital allocation [3] - Future capital raises will be linked to specific milestones rather than open-ended development programs [3] Leadership Changes - The Chief Science Officer, Colin van der Kuur, has departed, and responsibilities have been redistributed among the existing technical leadership team [3] Commitment to Shareholder Value - The CEO emphasized that the reset is about protecting and rebuilding shareholder value, with confidence in the technical expertise and operating team to execute priorities [4] - The company will align its research and development efforts to support the three core platforms and implement new standards for transparency and reporting [4]